
    
      The study has 2 study groups. One group will receive one dose of GSK Biologicals' vaccine GSK
      134612 and the other group will receive one dose of licensed MenC-CRM197 vaccine. All
      subjects will have 2 blood samples taken: just before vaccination and one month after
      vaccination.
    
  